Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$232.23−4.75 (-2.00%)
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Life Sciences by Quarter
Life Sciences — Intangibles Amortization % of Segment Sales (MD&A) (%)
Danaher Life Sciences: 8.2% in Q3 2026, down 0.4 pts from a year earlier.
Latest, Q3 2026
8.2%
Period ended Sep 30, 2026
Change on a year earlier
-0.4 pts
8.6% in Q3 2025
History
21 quarters
Since Q1 2020
Sources
18
Documents cited below
Where the Q3 2026 figure comes from
Source: Danaher SEC 10-Q (2026Q3, filed 2026-10-21) ↗
Reported for Q1, Q2, Q3 (10-Q) and full year (10-K), with no standalone Q4 reported.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Danaher Life Sciences (%), quarterly Q1 2020–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/mda-amort-pct-sales-lifesci
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.